HEADER CHAPERONE 21-MAR-06 2GFD TITLE GRP94 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN OF GRP94 RESIDUES (69-337); COMPND 5 SYNONYM: 94 KDA GLUCOSE-REGULATED PROTEIN, GRP94; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEX-NB-GRP94 KEYWDS GRP94, HSP82, HSP90, HTPG, CHAPERONE, LIGAND, RADICICOL, KEYWDS 2 GELDANAMYCIN, RADESTER, RADAMIDE EXPDTA X-RAY DIFFRACTION AUTHOR R.M.IMMORMINO,D.T.GEWIRTH REVDAT 5 30-AUG-23 2GFD 1 REMARK SEQADV REVDAT 4 02-AUG-17 2GFD 1 SOURCE REVDAT 3 24-NOV-10 2GFD 1 JRNL REVDAT 2 24-FEB-09 2GFD 1 VERSN REVDAT 1 03-APR-07 2GFD 0 JRNL AUTH R.M.IMMORMINO,L.E.METZGER,P.N.REARDON,D.E.DOLLINS,B.S.BLAGG, JRNL AUTH 2 D.T.GEWIRTH JRNL TITL DIFFERENT POSES FOR LIGAND AND CHAPERONE IN INHIBITOR-BOUND JRNL TITL 2 HSP90 AND GRP94: IMPLICATIONS FOR PARALOG-SPECIFIC DRUG JRNL TITL 3 DESIGN. JRNL REF J.MOL.BIOL. V. 388 1033 2009 JRNL REFN ISSN 0022-2836 JRNL PMID 19361515 JRNL DOI 10.1016/J.JMB.2009.03.071 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2313774.130 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 24181 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2443 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3590 REMARK 3 BIN R VALUE (WORKING SET) : 0.2620 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 378 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 284 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.43000 REMARK 3 B22 (A**2) : 4.81000 REMARK 3 B33 (A**2) : 3.62000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.660 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.440 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.350 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.100 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 53.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : 1PE_XPLOR_PARAM.PARAM REMARK 3 PARAMETER FILE 4 : PG4_XPLOR_PARAM.PARAM REMARK 3 PARAMETER FILE 5 : SEMI_WEAK_RAD.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : 1PE_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 4 : PG4_XPLOR_TOP.TOP REMARK 3 TOPOLOGY FILE 5 : RADAMIDE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GFD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000037047. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : SAGITAL CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29502 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38600 REMARK 200 FOR SHELL : 5.610 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YT1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS PH 8.0 25-30% PEG MME 550 REMARK 280 10-50 MM MGCL2 .5-1UL LIGAND (IN DMSO) PER 50 PROTEIN FOR FINAL REMARK 280 CONC ~5-10MM , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.74500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.79000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.28500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.79000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.74500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.28500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: EACH PROTOMER IN THE ASYMMETRICT UNIT COMPRISES AN ASSUMED REMARK 300 BIOLOGICAL MOLECULE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 65 REMARK 465 SER A 66 REMARK 465 HIS A 67 REMARK 465 MET A 68 REMARK 465 LEU A 69 REMARK 465 ARG A 70 REMARK 465 GLU A 71 REMARK 465 LYS A 72 REMARK 465 SER A 73 REMARK 465 ALA A 167 REMARK 465 SER A 169 REMARK 465 ALA A 181 REMARK 465 GLN A 182 REMARK 465 GLU A 183 REMARK 465 ASP A 184 REMARK 465 GLY A 185 REMARK 465 GLN A 186 REMARK 465 GLY A 287 REMARK 465 GLY A 288 REMARK 465 GLY A 289 REMARK 465 GLY A 290 REMARK 465 GLY B 65 REMARK 465 SER B 66 REMARK 465 HIS B 67 REMARK 465 MET B 68 REMARK 465 LEU B 69 REMARK 465 ARG B 70 REMARK 465 GLU B 71 REMARK 465 LYS B 72 REMARK 465 SER B 73 REMARK 465 LYS B 168 REMARK 465 SER B 169 REMARK 465 GLU B 183 REMARK 465 ASP B 184 REMARK 465 GLY B 185 REMARK 465 GLN B 186 REMARK 465 GLY B 287 REMARK 465 GLY B 288 REMARK 465 GLY B 289 REMARK 465 GLY B 290 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 94 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 GLU A 130 CG CD OE1 OE2 REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 GLU A 253 CG CD OE1 OE2 REMARK 470 ASP A 262 CG OD1 OD2 REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 GLN A 273 CG CD OE1 NE2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 328 CG CD CE NZ REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 LYS B 140 CG CD CE NZ REMARK 470 GLU B 141 CG CD OE1 OE2 REMARK 470 GLU B 157 CG CD OE1 OE2 REMARK 470 GLU B 173 CG CD OE1 OE2 REMARK 470 GLU B 180 CG CD OE1 OE2 REMARK 470 GLN B 182 CG CD OE1 NE2 REMARK 470 GLU B 190 CG CD OE1 OE2 REMARK 470 GLN B 194 CG CD OE1 NE2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 LYS B 328 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 96 59.67 -140.53 REMARK 500 ASN A 129 115.53 -170.29 REMARK 500 SER A 227 -12.68 89.72 REMARK 500 GLU A 229 175.50 173.03 REMARK 500 ASN B 96 56.38 -144.21 REMARK 500 ASN B 129 112.63 -173.32 REMARK 500 THR B 150 45.30 -106.92 REMARK 500 SER B 227 -7.57 88.05 REMARK 500 GLU B 229 178.54 173.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 ONLY FRAGMENTS OF PEG400 WERE IDENTIFIED AND IN REMARK 600 MANY CASES SEVERAL ATOMS WERE MISSING DUE TO LACK OF REMARK 600 ELECTRON DENSITY. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RDA A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE RDA B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1PE B 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FYP RELATED DB: PDB REMARK 900 GRP94 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE REMARK 900 RELATED ID: 2FXS RELATED DB: PDB REMARK 900 YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADAMIDE REMARK 900 RELATED ID: 1ZWH RELATED DB: PDB REMARK 900 YEAST HSP82 IN COMPLEX WITH THE NOVEL HSP90 INHIBITOR RADESTER AMINE REMARK 900 RELATED ID: 1QY8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 REMARK 900 IN COMPLEX WITH RADICICOL REMARK 900 RELATED ID: 1U0Z RELATED DB: PDB REMARK 900 N-DOMAIN OF GRP94 LACKING THE CHARGED DOMAIN IN COMPLEX WITH REMARK 900 RADICICOL REMARK 900 RELATED ID: 1OSF RELATED DB: PDB REMARK 900 HUMAN HSP90 IN COMPLEX WITH 17-DESMETHOXY-17-N, N- REMARK 900 DIMETHYLAMINOETHYLAMINO-GELDANAMYCIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE DATABASE RESIDUES 287-327 WERE DELETED REMARK 999 AND REPLACED BY 4 GLYCINES. DBREF 2GFD A 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2GFD A 328 337 UNP P41148 ENPL_CANFA 328 337 DBREF 2GFD B 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2GFD B 328 337 UNP P41148 ENPL_CANFA 328 337 SEQADV 2GFD GLY A 65 UNP P41148 CLONING ARTIFACT SEQADV 2GFD SER A 66 UNP P41148 CLONING ARTIFACT SEQADV 2GFD HIS A 67 UNP P41148 CLONING ARTIFACT SEQADV 2GFD MET A 68 UNP P41148 CLONING ARTIFACT SEQADV 2GFD GLY A 287 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY A 288 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY A 289 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY A 290 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY B 65 UNP P41148 CLONING ARTIFACT SEQADV 2GFD SER B 66 UNP P41148 CLONING ARTIFACT SEQADV 2GFD HIS B 67 UNP P41148 CLONING ARTIFACT SEQADV 2GFD MET B 68 UNP P41148 CLONING ARTIFACT SEQADV 2GFD GLY B 287 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY B 288 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY B 289 UNP P41148 SEE REMARK 999 SEQADV 2GFD GLY B 290 UNP P41148 SEE REMARK 999 SEQRES 1 A 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 A 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 A 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 A 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 A 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 A 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 A 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 A 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 A 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 A 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 A 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 A 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 A 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 A 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 A 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 A 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 A 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 A 236 MET ASN SEQRES 1 B 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 B 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 B 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 B 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 B 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 B 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 B 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 B 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA LYS SEQRES 9 B 236 SER GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 B 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 B 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 B 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 B 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 B 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 B 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 B 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 B 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 B 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 B 236 MET ASN HET RDA A1001 56 HET PG4 A 501 13 HET PG4 A 502 13 HET RDA B1002 56 HET PG4 B 504 13 HET PG4 B 505 13 HET 1PE B 601 16 HETNAM RDA METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL) HETNAM 2 RDA AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN 1PE PEG400 FORMUL 3 RDA 2(C18 H18 CL N O8) FORMUL 4 PG4 4(C8 H18 O5) FORMUL 9 1PE C10 H22 O6 FORMUL 10 HOH *284(H2 O) HELIX 1 1 GLN A 79 LEU A 93 1 15 HELIX 2 2 GLU A 98 ASP A 122 1 25 HELIX 3 3 ASN A 124 ASN A 129 5 6 HELIX 4 4 THR A 155 THR A 165 1 11 HELIX 5 5 GLY A 170 GLU A 180 1 11 HELIX 6 6 THR A 188 GLY A 196 1 9 HELIX 7 7 VAL A 197 LEU A 204 5 8 HELIX 8 8 GLU A 253 LEU A 259 5 7 HELIX 9 9 GLU A 260 SER A 272 1 13 HELIX 10 10 GLN B 79 TYR B 94 1 16 HELIX 11 11 GLU B 98 ASP B 122 1 25 HELIX 12 12 ASN B 124 ASN B 129 5 6 HELIX 13 13 THR B 155 THR B 165 1 11 HELIX 14 14 GLY B 170 GLN B 182 1 13 HELIX 15 15 THR B 188 GLY B 196 1 9 HELIX 16 16 VAL B 197 LEU B 204 5 8 HELIX 17 17 GLU B 253 LEU B 259 5 7 HELIX 18 18 GLU B 260 SER B 272 1 13 SHEET 1 A 9 LYS A 75 PHE A 76 0 SHEET 2 A 9 PHE A 230 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N LEU A 145 O LEU A 249 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N LYS A 135 O THR A 148 SHEET 8 A 9 ILE A 279 LYS A 285 1 O TYR A 280 N VAL A 134 SHEET 9 A 9 VAL A 330 LEU A 335 -1 O ASP A 332 N SER A 283 SHEET 1 B 9 LYS B 75 PHE B 76 0 SHEET 2 B 9 PHE B 230 ALA B 234 -1 O PHE B 230 N PHE B 76 SHEET 3 B 9 HIS B 221 SER B 225 -1 N ILE B 222 O ILE B 233 SHEET 4 B 9 ALA B 206 LYS B 214 -1 N VAL B 211 O TRP B 223 SHEET 5 B 9 GLY B 244 LEU B 251 -1 O THR B 248 N ILE B 210 SHEET 6 B 9 LEU B 144 ASP B 149 -1 N LEU B 145 O LEU B 249 SHEET 7 B 9 VAL B 134 ASP B 139 -1 N LYS B 135 O THR B 148 SHEET 8 B 9 ILE B 279 LYS B 285 1 O TYR B 280 N ILE B 136 SHEET 9 B 9 VAL B 330 LEU B 335 -1 O VAL B 330 N LYS B 285 SITE 1 AC1 17 ASN A 107 ALA A 111 ASP A 149 MET A 154 SITE 2 AC1 17 ASN A 162 ILE A 166 LYS A 168 GLY A 196 SITE 3 AC1 17 VAL A 197 PHE A 199 TYR A 200 THR A 245 SITE 4 AC1 17 ILE A 247 HOH A1004 HOH A1005 HOH A1007 SITE 5 AC1 17 HOH A1084 SITE 1 AC2 18 ASN B 107 ALA B 111 ASP B 149 MET B 154 SITE 2 AC2 18 ASN B 162 LEU B 163 ILE B 166 GLY B 196 SITE 3 AC2 18 VAL B 197 PHE B 199 TYR B 200 THR B 245 SITE 4 AC2 18 ILE B 247 HOH B1003 HOH B1006 HOH B1043 SITE 5 AC2 18 HOH B1093 HOH B1140 SITE 1 AC3 11 THR A 212 ARG A 237 THR A 248 PG4 A 502 SITE 2 AC3 11 HOH A1003 HOH A1029 HOH A1046 HOH A1078 SITE 3 AC3 11 HOH A1095 HOH A1101 HOH A1120 SITE 1 AC4 5 LYS A 137 HIS A 146 THR A 148 PG4 A 501 SITE 2 AC4 5 HOH A1074 SITE 1 AC5 8 THR B 212 ARG B 237 THR B 240 THR B 246 SITE 2 AC5 8 THR B 248 HOH B1032 HOH B1120 HOH B1123 SITE 1 AC6 3 LYS B 137 THR B 148 TRP B 282 SITE 1 AC7 8 ASN A 83 LYS A 87 ILE A 90 ASN B 83 SITE 2 AC7 8 LYS B 87 ILE B 90 SER B 227 HOH B1069 CRYST1 65.490 84.570 95.580 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015270 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011825 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010462 0.00000